The mRNA expression of CASP6 and DNM1L increased significantly, whereas that of SNHG16 significantly decreased in the MASLD group (p < 0.05) (Figure 6H–J). This evidence concerns the gene CASP6 and metabolic dysfunction-associated steatotic liver disease.